147 related articles for article (PubMed ID: 21982950)
1. Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrence.
Morin A; Fritsch L; Mathieu JR; Gilbert C; Guarmit B; Firlej V; Gallou-Kabani C; Vieillefond A; Delongchamps NB; Cabon F
FASEB J; 2012 Jan; 26(1):460-7. PubMed ID: 21982950
[TBL] [Abstract][Full Text] [Related]
2. Appearance of CAD activity, the rate-limiting enzyme for pyrimidine biosynthesis, as B cells progress into and through the G1 stage of the cell cycle.
Morford G; Davidson JN; Snow EC
Cell Immunol; 1994 Oct; 158(1):96-104. PubMed ID: 7916269
[TBL] [Abstract][Full Text] [Related]
3. Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis.
Robitaille AM; Christen S; Shimobayashi M; Cornu M; Fava LL; Moes S; Prescianotto-Baschong C; Sauer U; Jenoe P; Hall MN
Science; 2013 Mar; 339(6125):1320-3. PubMed ID: 23429704
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
Gregory CW; Johnson RT; Mohler JL; French FS; Wilson EM
Cancer Res; 2001 Apr; 61(7):2892-8. PubMed ID: 11306464
[TBL] [Abstract][Full Text] [Related]
5. Function of the polypeptide chain segment connecting the dihydroorotase and aspartate transcarbamylase domains in the mammalian multifunctional CAD.
Guy HI; Evans DR
Adv Exp Med Biol; 1994; 370():729-33. PubMed ID: 7661008
[No Abstract] [Full Text] [Related]
6. Interrogating androgen receptor function in recurrent prostate cancer.
Zhang L; Johnson M; Le KH; Sato M; Ilagan R; Iyer M; Gambhir SS; Wu L; Carey M
Cancer Res; 2003 Aug; 63(15):4552-60. PubMed ID: 12907631
[TBL] [Abstract][Full Text] [Related]
7. carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (cad) regulates Notch signaling and vascular development in zebrafish.
Coxam B; Neyt C; Grassini DR; Le Guen L; Smith KA; Schulte-Merker S; Hogan BM
Dev Dyn; 2015 Jan; 244(1):1-9. PubMed ID: 25294789
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional repression of human cad gene by hypoxia inducible factor-1alpha.
Chen KF; Lai YY; Sun HS; Tsai SJ
Nucleic Acids Res; 2005; 33(16):5190-8. PubMed ID: 16155188
[TBL] [Abstract][Full Text] [Related]
9. The multienzymatic protein CAD leading the de novo biosynthesis of pyrimidines localizes exclusively in the cytoplasm and does not translocate to the nucleus.
Del Caño-Ochoa F; Ramón-Maiques S
Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1320-1334. PubMed ID: 31997698
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells.
Khan S; Abdelrahim M; Samudio I; Safe S
Endocrinology; 2003 Jun; 144(6):2325-35. PubMed ID: 12746293
[TBL] [Abstract][Full Text] [Related]
11. Allosteric regulation and substrate channeling in multifunctional pyrimidine biosynthetic complexes: analysis of isolated domains and yeast-mammalian chimeric proteins.
Serre V; Guy H; Liu X; Penverne B; Hervé G; Evans D
J Mol Biol; 1998 Aug; 281(2):363-77. PubMed ID: 9698553
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical analysis of the domain structure of CAD, the multifunctional protein that initiates pyrimidine biosynthesis in mammalian cells.
Grayson DR; Lee L; Evans DR
J Biol Chem; 1985 Dec; 260(29):15840-9. PubMed ID: 2866187
[TBL] [Abstract][Full Text] [Related]
13. Pyrimidine Biosynthetic Enzyme CAD: Its Function, Regulation, and Diagnostic Potential.
Li G; Li D; Wang T; He S
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638594
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease.
Ricciardelli C; Choong CS; Buchanan G; Vivekanandan S; Neufing P; Stahl J; Marshall VR; Horsfall DJ; Tilley WD
Prostate; 2005 Apr; 63(1):19-28. PubMed ID: 15378523
[TBL] [Abstract][Full Text] [Related]
15. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ
Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
[TBL] [Abstract][Full Text] [Related]
17. Nuclear localization and mitogen-activated protein kinase phosphorylation of the multifunctional protein CAD.
Sigoillot FD; Kotsis DH; Serre V; Sigoillot SM; Evans DR; Guy HI
J Biol Chem; 2005 Jul; 280(27):25611-20. PubMed ID: 15890648
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.
Kahl P; Gullotti L; Heukamp LC; Wolf S; Friedrichs N; Vorreuther R; Solleder G; Bastian PJ; Ellinger J; Metzger E; Schüle R; Buettner R
Cancer Res; 2006 Dec; 66(23):11341-7. PubMed ID: 17145880
[TBL] [Abstract][Full Text] [Related]
19. Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells.
Attardi BJ; Burgenson J; Hild SA; Reel JR
Mol Cell Endocrinol; 2004 Jul; 222(1-2):121-32. PubMed ID: 15249132
[TBL] [Abstract][Full Text] [Related]
20. Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis.
Diallo JS; Aldejmah A; Mouhim AF; Fahmy MA; Koumakpayi IH; Sircar K; Bégin LR; Mes-Masson AM; Saad F
BJU Int; 2008 May; 101(10):1302-9. PubMed ID: 18294307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
